PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
06-May-2020 CORRECTION  - Polygon request special audit of Biotest AG in connection with the Proposed Appointment of Competitor CEO to its Supervisory Board Polygon Global Partners LLP
06-May-2020 United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020 United Therapeutics Corporation
06-May-2020 Targovax Announces That Abstract on Interim Phase I Clinical Data From the Phase I/II Peritoneal Trial is Accepted at ASCO Targovax
06-May-2020 FDA approves new treatment for a type of heart failure U.S. Food and Drug Administration
05-May-2020 Richmond Research Institute partnering to ensure faster COVID-19 point of care testing and longer-term immunity studies Richmond Research Institute
05-May-2020 Stilla Technologies offers a digital PCR solution to detect Covid-19 infections more sensitively and more accurately than the current RT-PCR method Stilla Technologies
05-May-2020 Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020 Invitae Corporation
05-May-2020 Rigel Reports First Quarter 2020 Financial Results and Provides Business Update Rigel Pharmaceuticals, Inc.
05-May-2020 Independent expert review of data supports the potential of XF-73 to address antimicrobial resistance Destiny Pharma
05-May-2020 Libtayo® (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma Regeneron Pharmaceuticals, Inc.
05-May-2020 Algenex advances insect-based vaccine production technology in human health Algenex SL
05-May-2020 Libtayo® (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma Regeneron Pharmaceuticals, Inc.
05-May-2020 Approval of targeted therapies first line for prostate cancer ‘will ease Covid-19 pressures’ The Institute of Cancer Research
05-May-2020 Evonik announces €25m first stage of program to increase contract manufacturing of APIs and intermediates in Germany Evonik
05-May-2020 Pioneering Roswell Park-Led Research Effort Applies Precision Medicine to Better Understand COVID-19 Roswell Park Comprehensive Cancer Center
05-May-2020 Nordic Nanovector Announces Changes to its Executive Management Team Nordic Nanovector
05-May-2020 CEL-SCI’s Pivotal Phase 3 Study Has Reached the Required Number of Events to Evaluate Data for Multikine in Treatment of Head and Neck Cancer CEL-SCI Corporation
05-May-2020 Biomaterial immune control discoveries could reduce implant rejection The University of Nottingham
05-May-2020 Vaxxel acquires Transgene's DuckCelt®-T17 cell line to develop industrial-scale vaccines against respiratory viruses Vaxxel SAS
05-May-2020 Freeline receives Orphan Drug Designation from the FDA for FLT190 for the treatment of Fabry Disease Freeline